Allogene Therapeutics Inc (ALLO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

210 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080

Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.

View SEC Filings from ALLO instead.
Q1 2019 All Institutions Hedge Funds 1
To trade ALLO now:
Filers who had this stock in their top 10: 3 0 (0.0%)
13F Filers holding this stock: 85 10 (1.02%)
Aggregate 13F shares on 03/31/2019: 64.988 Million 5.816 Million
Aggregate 13F shares on 12/31/2018: 62.679 Million 5.971 Million
Percent change: 3.68% -2.59%
Funds creating new positions: 19 2
Funds Adding to an existing position: 29 3
Funds closing out their position: 13 9
Funds reducing their position: 18 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALLO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.9 Million total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

21,216,306 2019-05-14 3

CHANG DAVID D PRESIDENT AND CEO

  • Officer
  • Director
4,991,687 2019-05-13 5

BELLDEGRUN ARIE

  • Director
10,858,676 2019-05-13 6

KAZAM JOSHUA A

  • Director
0 2019-05-10 2

HUMER FRANZ B

  • Director
23,973 2019-04-01 2

MOORE ALISON CHIEF TECHNICAL OFFICER

  • Officer
37,050 2019-03-13 2

SCHMIDT ERIC THOMAS CHIEF FINANCIAL OFFICER

  • Officer
1,514,150 2019-03-13 2

MESSEMER DEBORAH M.

  • Director
1,057 2019-01-16 2

WITTE OWEN N.

  • Director
236,182 2018-10-15 2

PFIZER INC

  • 10% Owner
22,032,040 2018-10-15 2

DEYOUNG JOHN A.

  • Director
0 2018-10-10 1

SISITSKY TODD BENJAMIN

  • Director
0 2018-10-10 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

TPG GROUP HOLDINGS (SBS) ADVISORS, INC. see explanation of responses

BONDERMAN DAVID see explanation of responses

COULTER JAMES G see explanation of responses

2019-05-14 S 1,918,755 $29.38 d 21,216,306 21,216,306.00 indirect

BELLDEGRUN ARIE - Director see footnote

2019-05-13 J 13,413 a 515,076 10,858,676.00 indirect

CHANG DAVID D - Director - Officer PRESIDENT AND CEO see footnote

2019-05-13 J 11,753 a 1,125,344 4,991,687.00 indirect yes

BELLDEGRUN ARIE - Director see footnote

2019-05-13 J 598,935 d 4,791,480 10,858,676.00 indirect yes

CHANG DAVID D - Director - Officer PRESIDENT AND CEO see footnote

2019-04-26 J 11,753 a 1,113,591 4,979,934.00 indirect yes

BELLDEGRUN ARIE - Director see footnote

2019-04-26 J 13,413 a 501,663 11,444,198.00 indirect

BELLDEGRUN ARIE - Director see footnote

2019-04-26 J 598,937 d 5,390,415 11,444,198.00 indirect yes
Click here to report any possible errors with this stock listing.

Elevate your investments